Search - tctmd.com

Displaying 481 - 500 of 558

Sort: Relevancy | Date

News Daily News

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Jason Kahn

December 17, 2012

Presentation AHA 2012

First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial: The TRILOGY ACS — Platelet Function Substudy

Presenter: Paul A. Gurbel

November 04, 2012

News Conference News AHA 2012

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

November 04, 2012

News Conference News TCT 2012

Biomarkers May Identify Risky Subcritical Lesions

October 30, 2012

Presentation TCT 2012

Novel Anticoagulants in Patients with Acute Coronary Syndromes

Presenter: C. Michael Gibson

October 25, 2012

Presentation TCT 2012

Case 4: The Patient with Atrial Fibrillation Presenting with an Acute Coronary Syndrome

Presenter: Michael Ezekowitz

October 24, 2012

Presentation TCT 2012

ATLAS ACS-2 TIMI 51: Stent thrombosis in Patients with Acute Coronary Syndromes treated with Rivaroxaban

Presenter: C. Michael Gibson

October 24, 2012

Presentation TCT 2012

TCT-53. Assessment of 30-day Rehospitalization for Acute Myocardial Infarction in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention: A...

Presenter: Jay Bae

October 23, 2012

News Daily News

Urgent Invasive Strategy Key for Out-of-Hospital Arrest Patients with ACS

Jason Kahn

October 23, 2012

Presentation TCT 2012

Pharmacotherapy for Acute Coronary Syndromes/NSTEMI

Presenter: Emmanouil Brilakis

October 22, 2012

Presentation TCT 2012

PCI in Acute Coronary Syndromes and NSTEMI: Guidelines, Strategies and Outcomes

Presenter: George Dangas

October 22, 2012

Presentation TCT 2012

Acute Coronary Syndromes: STEMI

Presenter: Michael Kim

October 21, 2012

Presentation TCT 2012

Acute Coronary Syndromes: NSTEMI

Presenter: Duane Pinto

October 21, 2012

News Daily News

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

September 27, 2012

News Daily News

La Estrategia Precoz Agresiva en Pacientes Ancianos con SCASEST No es Perjudicial aunque la Ventaja sigue siendo Elusiva

Caitlin E. Cox

September 20, 2012

News Daily News

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

Caitlin E. Cox

September 20, 2012

Presentation ESC 2012

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Presenter: Matthew Roe

August 28, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Daily News

PCI Plus Extracorporeal Oxygenation Improves Outcomes After Cardiac Arrest

Caitlin E. Cox

August 24, 2012

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

Advertisement

Genetic Alleles Affect Response to Prasugrel in ACS Patients

First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial: The TRILOGY ACS — Platelet Function Substudy

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

Biomarkers May Identify Risky Subcritical Lesions

Novel Anticoagulants in Patients with Acute Coronary Syndromes

Case 4: The Patient with Atrial Fibrillation Presenting with an Acute Coronary Syndrome

ATLAS ACS-2 TIMI 51: Stent thrombosis in Patients with Acute Coronary Syndromes treated with Rivaroxaban

TCT-53. Assessment of 30-day Rehospitalization for Acute Myocardial Infarction in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention: A...

Urgent Invasive Strategy Key for Out-of-Hospital Arrest Patients with ACS

Pharmacotherapy for Acute Coronary Syndromes/NSTEMI

PCI in Acute Coronary Syndromes and NSTEMI: Guidelines, Strategies and Outcomes

Acute Coronary Syndromes: STEMI

Acute Coronary Syndromes: NSTEMI

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

La Estrategia Precoz Agresiva en Pacientes Ancianos con SCASEST No es Perjudicial aunque la Ventaja sigue siendo Elusiva

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

PCI Plus Extracorporeal Oxygenation Improves Outcomes After Cardiac Arrest

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content